<DOC>
	<DOCNO>NCT00664222</DOCNO>
	<brief_summary>The purpose study evaluate effect spironolactone furosemide insulin resistance patient chronic heart failure .</brief_summary>
	<brief_title>Spironolactone Insulin Resistance Chronic Heart Failure ( CHF )</brief_title>
	<detailed_description>Diuretics useful CHF patient . On hand , deteriorate glucose metabolism . Therefore , purpose study evaluate effect spironolactone furosemide insulin resistance patient chronic heart failure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>chronic stable heart failure renal dysfunction treatment antidiabetic agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>heart failure</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>inflammatory cytokine</keyword>
	<keyword>spironolactone</keyword>
	<keyword>furosemide</keyword>
</DOC>